Type 2 diabetes risk alleles in peptidyl-glycine alpha-amidating monooxygenase influence GLP-1 levels and response to GLP-1 receptor agonists.

Umapathysivam MM., Araldi E., Hastoy B., Dawed AY., Vatandaslar H., Mayrhofer JE., Lindquist P., Silva PN., Goga A., TrĂ¼llinger GO., Godbersen S., Sengupta S., Kaufmann A., Thomsen SK., Hartmann B., Chen Y-C., Jonsson AE., Kabakci H., Thaman S., Grarup N., Have CT., Pallo LP., Faerch K., Gjesing AP., Nawaz S., Cheeseman J., Neville MJ., Pedersen O., Walker M., Sun H., Jennison C., Hattersley AT., Rehfeld JF., Holman RR., Verchere BC., Hansen T., Karpe F., Holst JJ., Rosenkilde MM., Jones AG., Ristow M., McCarthy MI., Pearson ER., Stoffel M., Gloyn AL.

DOI

10.1186/s13073-026-01630-0

Type

Conference paper

Publication Date

2026-03-29T00:00:00+00:00

Permalink More information Close